Evergreen Theragnostics was established in 2019 to be a leading US-based radiopharmaceutical Contract Development and Manufacturing Organization (CDMO). Our team’s unmatched expertise and track record in theragnostic radiopharmaceutical commercialization, manufacturing process development, and regulatory affairs management, make us your idealpartner for all of your radiopharmaceutical development, manufacturing, and commercialization needs.

Biotechnology

Evergreen Theragnostics

James Cook

Nancy Preston

Patrick Nolty, MS

Zhen Hua Lin, R.T. (R)

Megha Thakkar, PhD

Dipesh Patel

Thomas Reiner

Phillip De Noble, PharmD

Michael Patrick

Kyle Hoffmann

Alton Kwong

Giacomo Pirovano

Alison Tillbrook

Alex Agnoletto

The Business Development and Strategy team at Evergreen Theragnostics is responsible for identifying and pursuing new market opportunities, forging strategic partnerships, and enhancing market access for radiopharmaceutical products. They work collaboratively to drive commercialization efforts, ensure seamless project management, and support the company's growth by aligning discovery strategies with business development initiatives.

Business Development and Strategy

Leadership Team

Regulatory and Quality Assurance Team

Business Development and Strategy

About

Team members

Other teams at Evergreen Theragnostics

Leadership Team

Regulatory and Quality Assurance Team